A prospective, observational study comparing postoperative residual curarisation and early adverse respiratory events in patients reversed with neostigmine or sugammadex or after apparent spontaneous recovery

Anaesthesia and Intensive Care

Volumn 40, Issue 6, 2012, Pages 999-1006

  Camu, G V ^a   Smet, V ^a   De Jongh, K ^a   Vandeput, D ^a  

^a OLV HOSPITAL   (Belgium)

Author keywords

Neostigmine; Postoperative residual curarisation; Sugammadex

Indexed keywords

ATRACURIUM BESILATE; MIVACURIUM; NEOSTIGMINE; ROCURONIUM; SUGAMMADEX; SUXAMETHONIUM; CHOLINERGIC RECEPTOR STIMULATING AGENT; GAMMA CYCLODEXTRIN DERIVATIVE; OXYGEN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; EXTUBATION; FEMALE; HUMAN; INHALATION ANESTHESIA; INTRAVENOUS ANESTHESIA; INTUBATION; MAJOR CLINICAL STUDY; MALE; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR BLOCKING REVERSAL; NEUROMUSCULAR MONITORING; OBSERVATIONAL STUDY; OXYGEN SATURATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE RESIDUAL CURARISATION; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECOVERY ROOM; REPEAT PROCEDURE; RESPIRATION CONTROL; AGED; ANESTHETIC RECOVERY; BREATHING DISORDER; COMPARATIVE STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; TIME;

ADULT; AGED; ANESTHESIA RECOVERY PERIOD; BODY MASS INDEX; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MIDDLE AGED; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; OXYGEN; PARASYMPATHOMIMETICS; PROSPECTIVE STUDIES; RESPIRATION DISORDERS; TIME FACTORS;

EID: 84871876052     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1204000611     Document Type: Article

References (25)

1. Kopman AF, Zank LM, Ng J, Neuman GG. Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: should quantitative assessment of neuromuscular function be mandatory? Anesth Analg 2004; 98:102-106.
2. Kopman AF, Kopman DJ, Ng J, Zank LM. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function. J Clin Anesth 2005; 17:30-35.
3. Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112:1013-1022.
4. Mortensen CR, Berg H, el-Mahdy A, Viby-Mogensen J. Perioperative monitoring of neuromuscular transmission using acceleromyography prevents residual neuromuscular block following pancuronium. Acta Anaesthesiol Scand 1995; 39:797-801.
5. Baillard C, Gehan G, Reboul-Marty J, Larmignat P, Samama CM, Cupa M. Residual curarization in the recovery room after vecuronium. Br J Anaesth 2000; 84:394-395.
6. Hayes AH, Mirakhur RK, Breslin DS, Reid JE, McCourt KC. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia 2001; 56:312-318.
7. Gatke MR, Viby-Mogensen J, Rosenstock C, Jensen FS, Skovgaard LT. Postoperative muscle paralysis after rocuronium: less residual block when acceleromyography is used. Acta Anaesthesiol Scand 2002; 46:207-213.
8. Debaene B, Plaud B, Dilly M-P, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98:1042-1048.
9. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41:1095-1103.
10. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS et al. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology 2008; 109:389-398.
11. Baillard C, Clec'h C, Catineau J, Salhi F, Gehan G, Cupa M et al. Postoperative residual neuromuscular block: a survey of management. Br J Anaesth 2005; 95:622-626.
12. Cammu G, De Witte J, De Veylder J, Byttebier G, Vandeput D, Foubert L et al. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg 2006; 102:426-429.
13. Brull SJ, Ehrenwerth J, Silverman DG. Stimulation with submaximal current for train-of-four monitoring. Anesthesiology 1990; 72:629-632.
14. Videira RLR, Vieira JE. What rules of thumb do clinicians use to decide whether to antagonize nondepolarizing neuromuscular blocking drugs? Anesth Analg 2011; 113:1192-1196.
15. Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WGF, Heeringa M et al. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology 2007; 106:283-288.
16. Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology 2007; 106:935-943.
17. Schaller S, Fink H, Ulm K, Blobner M. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. Anesthesiology 2010; 113:1054-1060.
18. Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Vender JS et al. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology 2011; 115:946-954.
19. Sauer M, Stahn A, Soltesz S, Noeldge-Schomburg G, Mencke T. The influence of residual neuromuscular block on the incidence of critical respiratory events. A randomised, prospective, placebo-controlled trial. Eur J Anaesthesiol 2011; 28:842-848.
20. Butterly A, Bittner EA, George E, Sandberg WS, Eikermann M, Schmidt U. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. Br J Anaesth 2010; 105:304-309.
21. Heier T, Caldwell JE, Feiner JR, Liu L, Ward T, Wright PMC. Relationship between normalized adductor pollicis train-of-four ratio and manifestations of residual neuromuscular block: a study using acceleromyography during near steady-state concentrations of mivacurium. Anesthesiology 2010; 113:825-832.
22. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996; 312:1215-1218.
23. Claudius C, Skovgaard LT, Viby-Mogensen J. Is the performance of acceleromyography improved with preload and normalization? A comparison with mechanomyography. Anesthesiology 2009; 110:1261-1270.
24. Baillard C, Bourdiau S, Le Toumelin P, Ait Kaci F, Riou B, Cupa M et al. Assessing residual neuromuscular blockade using acceleromyography can be deceptive in postoperative awake patients. Anesth Analg 2004; 98:854-857.
25. Schreiber J-U, Mucha E, Fuchs-Buder T. Acceleromyography to assess neuromuscular recovery: is calibration before measurement mandatory? Acta Anaesthesiol Scand 2011; 55:328-331.